» Articles » PMID: 18341488

Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission

Overview
Specialty Gastroenterology
Date 2008 Mar 18
PMID 18341488
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Studies have identified abnormal characteristics of the gut microbiota in patients with active IBD, but whether the changes are causal or secondary to inflammation remains uncertain. We investigated dynamics of fecal microbiota in ulcerative colitis (UC) during remission by genomic technology.

Patients And Methods: Patients in clinical remission and on stable maintenance mesalazine therapy were recruited (N = 33). Fecal samples were collected at regular intervals over a period of 1 yr. Sixteen patients who remained in remission and eight healthy controls were included in the analysis. Variable V6 to V8 regions of the 16S rRNA gene in DNA extracts from fecal samples were amplified by polymerase chain reaction. Amplicons were separated by denaturant gradient gel electrophoresis, band profiles were compared by software, and similarity indices were calculated from densitometric curves.

Results: Band profiles showed unique patterns with low similarity index between individuals, suggesting host specificity in the predominant microbiota. Within the same individual, profiles were stable in controls but varied notably over time in patients. In controls, the similarity index was remarkably stable (78 +/- 8% mean +/- SD) over a period of 24 months. However, patients showed a steady decline in similarity index versus the initial profile, dropping down to 42 +/- 24% at month 3 of follow-up and to 23 +/- 19% at month 12 (P < 0.001). Biodiversity of the dominant microbiota, as estimated by number of bands, was lower in patients (17 +/- 4) than controls (23 +/- 4, P < 0.01).

Conclusion: Molecular analysis of fecal bacteria in patients with inactive UC shows low biodiversity and temporal instability.

Citing Articles

Causal role of the gut microbiome in certain human diseases: a narrative review.

Prosty C, Katergi K, Papenburg J, Lawandi A, Lee T, Shi H eGastroenterology. 2025; 2(3):e100086.

PMID: 39944364 PMC: 11770457. DOI: 10.1136/egastro-2024-100086.


Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in the gut commensal .

Flanagan K, Gassner K, Lang M, Ozelyte J, Hausmann B, Crepaz D mBio. 2025; 16(3):e0392824.

PMID: 39878512 PMC: 11898669. DOI: 10.1128/mbio.03928-24.


Exploring Dietary- and Disease-Related Influences on Flatulence and Fecal Odor Perception in Inflammatory Bowel Disease.

Pueschel L, Nothacker S, Kuhn L, Wedemeyer H, Lenzen H, Wiestler M J Clin Med. 2025; 14(1.

PMID: 39797221 PMC: 11720819. DOI: 10.3390/jcm14010137.


Multiomics analysis reveals the potential mechanism of high-fat diet in dextran sulfate sodium-induced colitis mice model.

Zhao Y, Chen Z, Dong R, Liu Y, Zhang Y, Guo Y Food Sci Nutr. 2024; 12(10):8309-8323.

PMID: 39479684 PMC: 11521715. DOI: 10.1002/fsn3.4426.


Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis.

Arzamendi M, Habibyan Y, Defaye M, Shute A, Baggio C, Chan R Gut Microbes. 2024; 16(1):2409207.

PMID: 39360560 PMC: 11451282. DOI: 10.1080/19490976.2024.2409207.